Tanja Loof

Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat

Stephanie Krämer, Yingrui Wang-Rosenke, Valeska Scholl et al. · American Journal of Physiology-Renal Physiology · 2007 · 65 citations

Glomerular Disease, Immunology, Renal Inflammation +24

Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition

Yingrui Wang, Stephanie Krämer, Tanja Loof et al. · American Journal of Physiology-Renal Physiology · 2005 · 57 citations

Glomerular Disease, Nitric Oxide, Cgmp Serves +19

Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis

Yingrui Wang, Stephanie Krämer, Tanja Loof et al. · Kidney International · 2005 · 53 citations · Full text

Glomerulonephritis, Autoimmune Disease, Medicine +10

Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril

Stephanie Krämer, Tanja Loof, Sebastian Martini et al. · American Journal of Physiology-Renal Physiology · 2005 · 40 citations

Glomerular Disease, Antifibrotic Therapy, Renal Pathology +21

Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis

Harm Peters, Yingrui Wang, Tanja Loof et al. · Kidney International · 2004 · 30 citations

Inflammation, Glomerulonephritis, Glomerular Disease +12